TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure

[GlobeNewswire] – – Based on healthy subject bioequivalence studies, improvements in absorption are projected to increase exposure levels by approximately 3-4 fold more

View todays social media effects on TGTX

View the latest stocks trending across Twitter. Click to view dashboard

See who TG is hiring next, click here to view